| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1794401 | F | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | 91,504 | assay format | PubChem BioAssays | |||
| 2. | ALA2114780 | F | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | Homo sapiens | 58,727 | cell-based format | PubChem BioAssays | ||
| 3. | ALA2114788 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | Homo sapiens | 103,470 | assay format | PubChem BioAssays | ||
| 4. | ALA1614236 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | Influenza A virus (A/WSN/1933(H1N1)) | 32,268 | assay format | PubChem BioAssays | ||
| 5. | ALA1614249 | B | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | Equus caballus | 42,059 | single protein format | PubChem BioAssays | ||
| 6. | ALA1614458 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | Homo sapiens | 75,376 | assay format | PubChem BioAssays | ||
| 7. | ALA1614416 | F | PUBCHEM_BIOASSAY: Screen for Chemicals that Inhibit the RAM Network - Dose Response with Drug Efflux Deficient Sensitized Control Strain. (Class of assay: confirmatory) [Related pubchem assays: 869, 1298, 868, 1307 ] | 1,244 | assay format | PubChem BioAssays | |||
| 8. | ALA1614544 | F | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | Homo sapiens | 36,150 | assay format | PubChem BioAssays | ||
| 9. | ALA1737902 | F | PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355] | 75,513 | assay format | PubChem BioAssays | |||
| 10. | ALA1737991 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | Homo sapiens | 51,376 | assay format | PubChem BioAssays | ||
| 11. | ALA1738442 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | Homo sapiens | 90,358 | assay format | PubChem BioAssays | ||
| 12. | ALA1738188 | F | PUBCHEM_BIOASSAY: Confirmation Assay for Identification of Novel General Anesthetics. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2323, AID2385, AID485281] | Equus caballus | 672 | assay format | PubChem BioAssays | ||
| 13. | ALA1794375 | B | PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278] | 83,389 | assay format | PubChem BioAssays | |||
| 14. | ALA2354254 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) | 153,867 | assay format | PubChem BioAssays | |||
| 15. | ALA3119030 | A | Cytotoxicity against human HuH7 cells assessed as cell viability after 17 hrs by MTT assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA3119031 | F | Inhibition of sphingomyelin synthase in ICR mouse assessed as decrease of sphingomyelin level in plasma at 6 mg/kg, ip after 2 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA3119032 | F | Inhibition of sphingomyelin synthase in ICR mouse assessed as decrease of sphingomyelin level in plasma at 6 mg/kg, iv after 2 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA3119033 | F | Inhibition of sphingomyelin synthase in ICR mouse assessed as increase of ceramide level in plasma at 6 mg/kg, ip after 2 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA3119034 | F | Inhibition of sphingomyelin synthase in ICR mouse assessed as increase of ceramide level in plasma at 6 mg/kg, iv after 2 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA3119035 | B | Inhibition of sphingomyelin synthase in ICR mouse liver homogenates using C6-NBD-Cer as substrate after 2 hrs | Mus musculus | 23 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!